CAROLUS THERAPEUTICS
Carolus Therapeutics, Inc. is a biopharmaceutical company committed to the development of innovative new drugs that will provide relief to patients suffering from a host of disorders triggered by acute and chronic inflammation. The clinical and commercialization focus of the company is on novel therapeutic strategies to noninvasively monitor and disrupt proinflammatory interactions of chemokines and prevent or reverse inflammation associated with a broad array of human diseases. The company’s patented technology represents a promising advance in inflammation therapy where the underlying disease, as opposed to the symptoms, is treated without significant side effect profiles.
CAROLUS THERAPEUTICS
Industry:
Biotechnology Clinical Trials Therapeutics
Founded:
2007-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.carolustherapeutics.com
Total Employee:
1+
Status:
Closed
Contact:
858-768-7823
Email Addresses:
[email protected]
Total Funding:
2.25 M USD
Technology used in webpage:
Apache Sectigo SSL Sectigo Domain SSL Bizland Choopa Endurance International Moniker DNS
Investors List
Square 1 Bank
Square 1 Bank investment in Debt Financing - Carolus Therapeutics
Official Site Inspections
http://www.carolustherapeutics.com
Unable to get host informations!!!
More informations about "Carolus Therapeutics"
Carolus Therapeutics - Overview, News & Similar companies
Carolus Therapeutics, Inc. is a biopharmaceutical company committed to the development of innovative new drugs that will provide relief to patients suffering from a host of disorders …See details»
Carolus Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Carolus Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, , Drug:Chemokine Inhibitors (Carolus Therapeutics).See details»
Carolus Therapeutics Company Profile | Management and
Carolus Therapeutics Profile and History. Carolus Therapeutics, Inc. is a biopharmaceutical company committed to the development of innovative new drugs that will provide relief to …See details»
Carolus Therapeutics Inc - Company Profile and News
Carolus Therapeutics, Inc. is a biopharmaceutical company. The Company develops drugs for the treatment of acute and chronic inflammatory diseases. Carolus mainly focuses on …See details»
Carolus - CoBee Company Profile & Funding Rounds
Carolus Therapeutics, Inc. is a biopharmaceutical company committed to the development of innovative new drugs that will provide relief to patients suffering from a host of disorders …See details»
Carolus Therapeutics - Tech Company Profile - Gaebler.com …
Carolus Therapeutics. Carolus Therapeutics is a biopharmaceutical company, based in La Jolla. Financial backing came from Square 1 Bank. Company Overview. Company Name. Carolus …See details»
Carolus Therapeutics, Inc.:Company Profile & Technical Research ...
Carolus Therapeutics, Inc. is a company that provides Inflammation, Medicine, Clinical trial and more. Carolus Therapeutics, Inc. is headquartered in United States California. Carolus …See details»
Carolus Therapeutics - Wikidata
Organization in La Jolla, United States. edit. Language ... Also known as; English: Carolus Therapeutics. organization in La Jolla, United States. Statements. instance of. organization. 1 …See details»
CAROLUS THERAPEUTICS, INC. :: California (US) - OpenCorporates
Free and open company data on California (US) company CAROLUS THERAPEUTICS, INC. (company number 3092865), 11099 NORTH TORREY PINES RD STE 290 LA JOLLA CA …See details»
Carolus Therapeutics - Funding, Financials, Valuation & Investors
Carolus Therapeutics develops innovative drugs for patients suffering from a host of disorders triggered by acute and chronic inflammation. Search Crunchbase. ... How much funding has …See details»
Carolus Therapeutics - Products, Competitors, Financials, …
San Diego’s Carolus Therapeutics Taps Advocate Group for R&D Support. Aug 27, 2013. XconomySan Diego — In an approach that taps the resources of a patient advocacy group, …See details»
Carolus Therapeutics - Company Profile - Tracxn
Carolus Therapeutics - Drugs for patients suffering from acute and chronic inflammation. Raised a total funding of $2.25M over 1 round from 2 investors. Carolus Therapeutics has 320 competitors.See details»
Corporate Profile: Carolus Therapeutics - The Lab Rat
Corporate Profile: Carolus Therapeutics. Summary: Carolus Therapeutics is focused on the development drugs to treat disorders triggered by acute and chronic inflammation. Address …See details»
Carolus Therapeutics | VentureRadar
Find out more about Carolus Therapeutics including the VentureRadar Innovation and Growth scores, Similar Companies and more. All; Ranked; Organisation Names; Apps and Links. …See details»
Carolus Therapeutics - Avalon Ventures
Carolus Therapeutics, Inc. is a biopharmaceutical company developing new treatments for cardiovascular and inflammatory diseases. Carolus develops first-in-class peptide and …See details»
Carolus Therapeutics CEO, Founder, Key Executive Team, Board of ...
Explore {Carolus Therapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Carolus Therapeutics Wants to be King of Cytokine Targeting
Jan 20, 2009 Their company may be young and, for the time being, mainly virtual, but the folks at Carolus Therapeutics do not shy away from thinking big. It’s named after Carolus Magnus, …See details»
Carolus Therapeutics Inc. :: HBW Insight
May 1, 2009 Macrophage migration inhibiting factor (MIF) has been a target for drug developers for years because of its potential to fight inflammation in a variety of indications. To date, …See details»
Carolus Therapeutics Inc. - Scrip
May 1, 2009 Macrophage migration inhibiting factor (MIF) has been a target for drug developers for years because of its potential to fight inflammation in a variety of indications. To date, …See details»